All blog posts
Total 23 results for
Showing 12 out of 23 results
03 3月 2025
Latest CRTea podcast now available: Navigating competition law and FDI regulation in the pharmaceuticals sector - 2025 Outlook
01 11月 2024
EU Commission fines Teva €462.6 million for misuse of divisional patents and disparagement campaign
03 10月 2024
How will the European Union develop over the next five years? Using Treaty Powers to promote Competitiveness and Security
29 7月 2024
Commission investigation into anticompetitive disparagement ends with commitments
04 7月 2024
Insights from the latest "pay-for-delay" CJEU judgments: fines on Servier and generics drug manufacturers largely upheld (but not over yet)
24 6月 2024
Overview of EU regulatory and competition law in the Pharma sector
19 2月 2024
Five Years of Activity in a Priority Sector: The European Commission's Report on Competition Enforcement in the Pharmaceutical Sector (2018-2022)
06 12月 2023
Competition law and biosimilars: Time for a new approach or not yet?
23 11月 2023
CMA issues guidance permitting drugs companies to work together on Combination Therapies
31 10月 2023
Another chapter in the "pay for delay" saga: General Court rules on the Teva-Cephalon settlement agreement
15 8月 2023
CAT upholds CMA excessive pricing decision in liothyronine tablets case
15 6月 2023
Overview of EU and South African regulatory and competition law in the Pharma sector
Showing 12 out of 23 results
View moreKey contacts
Kyriakos Fountoukakos
Managing Partner, Competition Regulation and Trade, Brussels
Veronica Roberts
Partner, UK Regional Head of Practice, Competition, Regulation and Trade, London
Linda Evans
Regional Head of Practice – Competition, Regulation and Trade, Australia, Sydney
